secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cadrenal Therapeutics, Inc. (CVKD)
CIK:        0001937993
Form:       8-K
Filed at:   2026-07-10T20:05:16+00:00
Accession:  0001213900-26-077134
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cadrenal Therapeutics CMO James J. Ferguson III resigns effective July 31, 2026
-------------------------------------------------------------------------------

- James J. Ferguson III, Chief Medical Officer, resigned effective July 31, 2026.
- Company is conducting a search for Dr. Ferguson's replacement.
- Company and Dr. Ferguson are negotiating terms of a separation agreement and release.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1937993/000121390026077134/0001213900-26-077134-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1937993/000121390026077134/ea0297603-8k_cadrenal.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-077134

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer